How does Zimmer Biomet Holdings (ZBH) make money?

Zimmer Biomet Holdings (ZBH) generates revenue primarily from Knees, which accounted for 42.6% of total revenue in TTM through Q1 2026. The company reported $8.41B in revenue and converted 9.1% of it into net profit, equivalent to roughly $761.30M in net income — what's left after the cost of revenue, operating expenses, interest, and income taxes.

What is the gross profit margin of Zimmer Biomet Holdings (ZBH)?

Zimmer Biomet Holdings (ZBH) reported a gross profit margin of 70% in TTM through Q1 2026, equivalent to $5.89B in gross profit on $8.41B in revenue. Gross margin measures how much of each dollar of revenue remains after the direct cost of producing or delivering the product — a higher figure typically signals pricing power, scale, or a less capital-intensive business model.

What is the operating profit margin of Zimmer Biomet Holdings (ZBH)?

Zimmer Biomet Holdings (ZBH) reported an operating profit margin of 15.6% in TTM through Q1 2026, equivalent to $1.31B in operating income. Operating margin captures profitability after research & development, sales & marketing, and general & administrative expenses — but before interest, taxes, and one-off items — and is the cleanest single read on the underlying business's efficiency.

What is the net profit margin of Zimmer Biomet Holdings (ZBH)?

Zimmer Biomet Holdings (ZBH) reported a net profit margin of 9.1% in TTM through Q1 2026, equivalent to $761.30M in net income. Net margin is the bottom-line share of revenue that survives every expense — operating costs, interest, and income taxes — and is the figure that flows directly into earnings per share.

Is Zimmer Biomet Holdings (ZBH) profitable?

Yes. Zimmer Biomet Holdings (ZBH) reported $761.30M in net income for TTM through Q1 2026, with a net profit margin of 9.1%. The company earned more from its operations than it paid out in costs, interest, and income taxes, leaving positive earnings on the bottom line.

How much does Zimmer Biomet Holdings (ZBH) invest in research and development?

Zimmer Biomet Holdings (ZBH) invested $451.40M in research and development during TTM through Q1 2026, roughly 5.4% of total revenue. R&D spending funds the company's future product pipeline and is expensed in full on the income statement rather than capitalised, which makes the operating margin sensitive to how aggressively management chooses to reinvest in innovation.

How much does Zimmer Biomet Holdings (ZBH) spend on capital expenditures?

Zimmer Biomet Holdings (ZBH) spent $162.10M on capital expenditures (CapEx) during TTM through Q1 2026, roughly 1.9% of total revenue. CapEx represents long-lived investment in property, equipment, data centres, and other physical infrastructure, and is subtracted from operating cash flow to arrive at free cash flow.

How much free cash flow does Zimmer Biomet Holdings (ZBH) generate?

Zimmer Biomet Holdings (ZBH) generated $1.84B in free cash flow during TTM through Q1 2026, a free-cash-flow margin of 21.8%. Free cash flow is the cash left after capital expenditures and represents the discretionary pool the company can use to pay dividends, repurchase shares, repay debt, or fund acquisitions without raising external capital.

What is the effective tax rate of Zimmer Biomet Holdings (ZBH)?

Zimmer Biomet Holdings (ZBH) had an effective tax rate of 15.8% in TTM through Q1 2026. The effective rate is the actual share of pre-tax income paid as income taxes and can differ materially from the statutory rate due to foreign earnings mix, tax credits (such as R&D), share-based compensation deductions, and one-off discrete items.

What are the main business segments of Zimmer Biomet Holdings (ZBH)?

Zimmer Biomet Holdings (ZBH) reports revenue across 4 reportable product segments, led by Knees at 42.6% of total revenue in TTM through Q1 2026. See the revenue-by-segment table on this page for the full breakdown and how each segment feeds into the income-statement waterfall above.

Where does Zimmer Biomet Holdings (ZBH) generate most of its revenue?

Americas is the largest geographic market for Zimmer Biomet Holdings (ZBH), accounting for 62.6% of revenue in the most recent annual filing. The complete regional split — including international markets and any Rest-of-World rollup — is shown in the revenue-by-geography table on this page.

How Zimmer Biomet Holdings Makes Money: 2026 Visual Revenue Map

Zimmer Biomet Holdings (ZBH) Income Statement Flow — TTM through Q1 2026

Calculated from the four most recent reported quarters, ending March 31, 2026 (reported May 1, 2026).

Zimmer Biomet Holdings (ZBH) Revenue by Product Segment — TTM through Q1 2026

Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported segments changed mid-year.

Revenue contribution by product segment for Zimmer Biomet Holdings (ZBH) in TTM through Q1 2026.
Segment	Revenue (USD)	% of total
Knees	$3.58B	42.6%
S E T	$2.39B	28.4%
Hips	$2.26B	26.9%
Other Product Category	$175.51M	2.1%
Total	$8.41B	100%

Knees$3.58B
S E T$2.39B
Hips$2.26B
Other Product Category$175.51M
Total$8.41B

Zimmer Biomet Holdings (ZBH) Revenue by Geography — TTM through Q1 2026

Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported regions changed mid-year.

Revenue contribution by geographic region for Zimmer Biomet Holdings (ZBH), TTM through Q1 2026
Region	Revenue (USD)	% of total
Americas	$5.26B	62.6%
E M E A	$1.88B	22.3%
Asia Pacific	$1.27B	15.1%
Total	$8.41B	100%

Americas
E M E A
Asia Pacific
Total

Revenue Breakdown — TTM through Q1 2026

In TTM through Q1 2026, Zimmer Biomet Holdings (ZBH) reports revenue across 4 operating segments; the largest segment was Knees at 42.6%, followed by S E T (28.4%) and Hips (26.9%). Separately, by end-market geography, Americas accounted for 62.6% of revenue, followed by E M E A (22.3%) and Asia Pacific (15.1%).

Frequently asked questions

Data & methodology

Zimmer Biomet Holdings (ZBH) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation